Background The use of blood biomarkers after mild traumatic brain injury (mTBI) has been
widely studied. We have identified eight unresolved issues related to the use of five …

Traumatic brain injury (TBI) is a heterogeneous condition, associated with diverse etiologies,
clinical presentations and degrees of severity, and may result in chronic neurobehavioral …

Objective To measure exosomal and plasma levels of candidate blood biomarkers in
veterans with history of mild traumatic brain injury (mTBI) and test their relationship with …

Importance Identifying plasma biomarkers associated with the amount of time an athlete may
need before they return to sport (RTS) following a sport-related concussion (SRC) is …

The purpose of this study was to examine the association of serum tau, neurofilament light
chain (NFL), glial fibrillary acidic protein (GFAP), and ubiquitin carboxy-terminal hydrolase …

After mild traumatic brain injury (mTBI), a substantial proportion of individuals do not fully
recover on the Glasgow Outcome Scale Extended (GOSE) or experience persistent post …

Considerable advancements have been made in the quantification of biofluid-based
biomarkers for traumatic brain injury (TBI), which provide a clinically accessible window to …

Traumatic brain injury (TBI) imposes a significant economic and social burden. The
diagnosis and prognosis of mild TBI, also called concussion, is challenging. Concussions …

Developing effective disease-modifying therapies for neurodegenerative diseases (NDs)
requires reliable diagnostic, disease activity, and progression indicators. While desirable …

Study Objectives Traumatic brain injury (TBI) is associated with chronic sleep disturbances
and cognitive impairment. Our prior preclinical work demonstrated dietary supplementation …